Seshadri Neervannan

Insider Reports History

Entity
Individual
Location
15440 Laguna Canyon Road, Suite 160, Irvine, CA
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Seshadri Neervannan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Common Stock 79.7K $3.99M $50.11 Mar 20, 2025 Direct
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Stock Option (right to buy) 30.6K $337K $10.99 Mar 5, 2025 Direct
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Restricted Stock Units 24.1K $310K $12.89 Mar 15, 2025 Direct

Insider Reports Filed by Seshadri Neervannan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARS Tarsus Pharmaceuticals, Inc. Mar 18, 2025 3 -$363K 4 Mar 20, 2025 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 15, 2025 4 $0 4 Mar 18, 2025 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 5, 2025 2 $0 4 Mar 7, 2025 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 15, 2024 4 -$149K 4 Mar 19, 2024 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 7, 2024 2 $0 4 Mar 11, 2024 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 21, 2023 3 -$14.3K 4 Mar 23, 2023 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 17, 2023 2 -$9.57K 4 Mar 21, 2023 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 15, 2023 3 -$4.79K 4 Mar 17, 2023 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 8, 2023 2 $0 4 Mar 10, 2023 Chief Operating Officer
TARS Tarsus Pharmaceuticals, Inc. Mar 9, 2022 2 $0 4 Mar 11, 2022 Chief Operating Officer